Aktis Oncology Alternatives & Competitors
12 companies similar to Aktis Oncology — Expanding the breakthrough potential of targeted radiopharmaceuticals to large c...
Companies similar to Aktis Oncology
Bicycle Therapeutics
Precision-Guided Therapeutics
Cambridge, United Kingdom
Fusion Pharmaceuticals
Based in Hamilton, ON & Boston, MA, Fusion is developing next-generation radiopharmaceutic...
Hamilton, Canada
Ablaze Pharmaceuticals
Leading the Innovative Targeted Radiotherapy Landscape in China.
Shanghai, China
KORTUC INC.
Revolutionzing Cancer Radiotherapy by the cutting edge technology from Japan.
Palo Alto, United States
Rival Readout
Competing with Aktis Oncology? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
United States
ITM Isotope Technologies Munich SE
Delivering the promise of radiopharmaceuticals to patients.
Germany
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
Oslo, Norway
South San Francisco, Unit...
FatiAbGen Inc.
Best in class multi-modality antibodies for difficult targets in high unmet need diseases...
Korea South
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
AVEO Oncology
Committed to delivering medicines that provide a better life for patients with cancer.
Boston, United States
Shasqi
Targeting cancer with click chemistry
San Francisco, United Sta...
About Aktis Oncology
Aktis Oncology is a clinical-stage company at the forefront of oncology innovation. With the compelling slogan, "Expanding the breakthrough potential of targeted radiopharmaceuticals to large cancer patient populations," the company underscores its commitment to addressing significant unmet needs in cancer treatment. F...
development of targeted radiopharmaceuticals, proprietary miniprotein radioconjugate platform, scientific research and innovation
cancer patients, oncologists, healthcare institutions, pharmaceutical partners
Targeted Radiopharmaceuticals, Oncology, Cancer Treatment, Clinical-Stage Company, Radioconjugate Platform, Miniprotein Technology, Nectin-4 Targeting, Tumor-Specific Delivery, Systemic Radiation Reduction, Pipeline Development, Multi-Indication Therapeutics, Strategic Collaboration, Pharmaceutical Innovation, Eli Lilly Partnership, Radioisotope Therapeutics
B2B, B2B2C
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Aktis Oncology: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Aktis Oncology on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
